Target intelligence / Profile preview

Reactive oxygen species production (ROS production) (ROS production)

Target
ROS production
Molecular classification
Other
01

Overview

Reactive oxygen species (ROS) production is a fundamental biological process involving the generation of highly reactive oxygen-containing molecules, including superoxide, hydrogen peroxide, and hydroxyl radicals [1]. These molecules are primarily produced as metabolic byproducts of the mitochondrial electron transport chain or by specialized enzymes such as NADPH oxidases (NOX) and xanthine oxidase [2, 3]. At physiological levels, ROS act as vital secondary messengers in signal transduction pathways regulating cell growth, differentiation, and immune responses [1]. However, excessive ROS production leads to oxidative stress, resulting in oxidative damage to cellular macromolecules like DNA, lipids, and proteins, which contributes to the pathogenesis of cancer, neurodegeneration, and cardiovascular diseases [4]. Therapeutic strategies targeting ROS production include the use of direct antioxidants to scavenge radicals or specific inhibitors to block enzymatic sources, though clinical success has been limited by the complexity of redox biology and the potential for disrupting beneficial signaling [5].

Other names
Cellular ROS productionROS generationOxidative stress inductionOxygen radical production
02

Mechanism of action

Pharmacological intervention involves the direct scavenging of reactive intermediates, the inhibition of enzymatic sources such as NADPH oxidase or xanthine oxidase, or the induction of endogenous antioxidant defense systems.

03

Biological functions

Signal transductionApoptosisImmune responseRedox signalingCell proliferation
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseDiabetes mellitus
05

Safety considerations

Disruption of physiological redox signalingPotential for the antioxidant paradox where supplementation increases mortalityInterference with essential immune-mediated pathogen killingRisk of promoting tumor survival or metastasis in established cancers
06

Interacting drugs

N-acetylcysteine

5 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)8-hydroxy-2'-deoxyguanosine (8-OHdG)Protein carbonylsReduced-to-oxidized glutathione ratio (GSH/GSSG)

Beyond the preview

Go deeper on Reactive oxygen species production (ROS production) (ROS production).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive oxygen species production (ROS production) (ROS production).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call